Accuray to Participate in Brean Capital's 2014 Life Science Conference

November 10, 2014 at 4:02 PM EST

SUNNYVALE, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY), announced today that its management is scheduled to participate in the Brean Capital 2014 Life Science Conference in New York City on Monday, November 24, 2014.

About Accuray

Accuray Incorporated (Nasdaq:ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com.

CONTACT: Investors: Lynn Pieper
         Investor Relations, Westwicke Partners
         +1 (415) 202-5678
         lynn.pieper@westwicke.com

         Media: Beth Kaplan
         Public Relations Director, Accuray
         +1 (408) 789-4426
         bkaplan@accuray.com
Accuray